References
- CondeDCostabelJPAlves de LimaARecent-onset atrial fibrillation in patients with left ventricular dysfunction: amiodarone or vernakalant?Can J Cardiol201329101330.e111330.e12
- Cadrin-TourignyJWyseDGRoyDEfficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trialsJ Cardiovasc Electrophysiol201425121306131325181386
- GoldschlagerNEpsteinAENaccarelliGVPractice Guidelines Sub-committee, North American Society of Pacing and Electrophysiology (HRS)A practical guide for clinicians who treat patients with amiodarone: 2007Heart Rhythm2007491250125917765636
- KirchhofPBenussiSKotechaDESC Scientific Document Group2016ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEur Heart J201637382893296227567408
- ChiangCEWuTJUengKC2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillationJ Formos Med Assoc20161151189395227890386
- FangJCEwaldGAAllenLAHeart Failure Society of America Guidelines CommitteeAdvanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines CommitteeJ Card Fail201521651953425953697
- PendyalAGelowJMCardiohepatic Interactions: implications for management in advanced heart failureHeart Fail Clin201612334936127371512
- HussainNBhattacharyyaAPrueksaritanondSAmiodarone-induced cirrhosis of liver: what predicts mortality?ISRN Cardiol2013201361794323577267
- LiverTox websiteBethesda, MDNational Institutes of Health2018 [updated 2018 April 18 cited 2018 April 20]Drug RecordAmiodarone Available from: https://livertox.nlm.nih.gov/Amiodarone.htm
- WuCYChenYJHoHJAssociation between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resectionJAMA2012308181906191423162861
- YuMLYehMLTsaiPCHuge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in TaiwanMedicine (Baltimore)20159413e69025837762
- LienHMChouSYLiuJTHospital ownership and performance: evidence from stroke and cardiac treatment in TaiwanJ Health Econ20082751208122318486978
- ChengCLChienHCLeeCHLinSJYangYHValidity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in TaiwanInt J Cardiol20152019610126292275
- AtiqMDavisJCLampsLWBelandSSRoseJEAmiodarone induced liver cirrhosis. Report of two casesJ Gastrointestin Liver Dis200918223323519565059
- PuliSRFraleyMAPuliVKupermanABAlpertMAHepatic cirrhosis caused by low-dose oral amiodarone therapyAm J Med Sci2005330525726116284489
- SamskyMDPatelCBDewaldTACardiohepatic interactions in heart failure: an overview and clinical implicationsJ Am Coll Cardiol201361242397240523603231
- MattarWJuliarBGradus-PizloIKwoPYAmiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failureJ Gastrointestin Liver Dis200918441942320076813
- PollakPTHow toxic is amiodarone to the liver?J Gastrointestin Liver Dis2010191111320361068
- LiawYFChuCMHepatitis B virus infectionLancet2009373966358259219217993
- LeeMHYangHIYuanYL’ItalienGChenCJEpidemiology and natural history of hepatitis C virus infectionWorld J Gastroenterol201420289270928025071320
- HazlehurstJMWoodsCMarjotTCobboldJFTomlinsonJWNonalcoholic fatty liver disease and diabetesMetabolism20166581096110826856933
- HossainNAfendyAStepanovaMIndependent predictors of fibrosis in patients with nonalcoholic fatty liver diseaseClin Gastroenterol Hepatol20097111224122919559819
- WangYXiongJNiuMStatins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studiesOncotarget2017835596665967628938670
- YuSTChangHYLinMCLinYHAgreement between self-reported and health insurance claims on utilization of health care: a population studyJ Clin Epidemiol200962121316132219403264